Moreover, some key pathways, such as oxidative phosphorylation, PPAR signalling pathway, primary immunodeficiency, and citrate cycle (TCA cycle), which have been reported to be involved in glioma progression, were highly enriched in the poor prognosis group18–21. The gene discussed is PPARA; the disease is central nervous system cancer.